Incheon Free Economic Zone Authority Participates in 'BIO USA 2020'... Online Video Investment Briefing

September 9-13, Over 3,000 Global Companies Participate
Active Promotion of Songdo Bio Cluster

Songdo G Tower, home to the Incheon Free Economic Zone Authority

[Asia Economy Reporter Park Hyesook] Amid the prolonged COVID-19 pandemic, which has significantly dampened domestic and international investment attraction activities, the Incheon Free Economic Zone Authority (IFEZA) is launching efforts to attract overseas investors through an online non-face-to-face video investment briefing session.

IFEZA will participate in 'BIO International Convention USA 2020 (BIO USA 2020),' the world's largest event in the bio sector, held from the 9th to the 13th.

Hosted by the Biotechnology Innovation Organization (BIO) of the United States, BIO USA 2020 is a comprehensive convention event attended annually by about 10,000 healthcare, bio, pharmaceutical, and life sciences experts, companies, and government officials from over 70 countries.

This year, due to the COVID-19 situation, the event has shifted from on-site visits to an online non-face-to-face format, with around 3,000 global companies such as Merck, Johnson & Johnson, AbbVie, and Pfizer expected to participate.

IFEZA is participating in this event together with the Korea Trade-Investment Promotion Agency (KOTRA). From the meeting room at Songdo G Tower, they plan to connect online with companies and institutions from various countries through the platform to conduct K-bio marketing activities leading the post-COVID-19 era.

In particular, they intend to actively promote the Songdo Bio Cluster, which boasts the world's largest biopharmaceutical production capacity based on a single city, to highlight that the Incheon Free Economic Zone is the optimal investment location with the best bioindustry infrastructure and an international city with excellent living conditions.

Additionally, they have requested one-on-one consultations with about 50 potential investors, including bio and medical-related companies and institutions suitable for attracting to Songdo. Major companies scheduled for investment attraction consultations so far include Italian pharmaceutical company I, French company S, and German company E, which develops non-invasive drug delivery products.

Lee Won-jae, head of IFEZA, stated, "We will focus our capabilities on attracting new industries such as medical, pharmaceutical, and bio industries that will lead the post-COVID-19 era and nurture the Songdo Bio Cluster as the representative 'K-bio' cluster."

This content was produced with the assistance of AI translation services.